Tracleer

Tracleer is a brand name of bosentan, approved by the FDA in the following formulation(s):

TRACLEER (bosentan - tablet; oral)

• 
  Manufacturer: ACTELION
  
  Approval date: November 20, 2001
  
  Strength(s): 125MG ^[RLD], 62.5MG
  

Has a generic version of Tracleer been approved?

No. There is currently no therapeutically equivalent version of Tracleer available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Tracleer. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Sulfonamides
  Patent 5,292,740
  Issued: March 8, 1994
  Inventor(s): Burri; Kaspar & Clozel; Martine & Fischli; Walter & Hirth; Georges & Loffler; Bernd-Michael & Neidhart; Werner & Ramuz; Henri
  Assignee(s): Hoffmann-La Roche Inc.
  The novel sulfonamides of formula I, ##STR1## in which the symbols R.sup.1 -R.sup.9, R.sup.a, R.sup.b, X, Y and n have the significance given in the description and salts thereof can be used for the treatment of circulatory disorders, especially hypertension, ischemia, vasopasms and angina pectoris.
  
  Patent expiration dates:
  
  
  • November 20, 2015
    
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • August 7, 2012 - INDICATION EXPANDED TO INCLUDE TREATMENT OF PULMONARY ARTENAL HYPERTENSION (WHO GROUP I) IN PATIENTS WITH CLASS II SYMPTOMS
  
  

See also...

• Tracleer Consumer Information (Wolters Kluwer)
• Tracleer Consumer Information (Cerner Multum)
• Tracleer Advanced Consumer Information (Micromedex)
• Tracleer AHFS DI Monographs (ASHP)
• Bosentan Consumer Information (Wolters Kluwer)
• Bosentan Consumer Information (Cerner Multum)
• Bosentan Advanced Consumer Information (Micromedex)
• Bosentan AHFS DI Monographs (ASHP)